Svizera Labs Private Limited, our manufacturing site for products for the treatment of Tuberculosis and other infectious diseases, is one of the largest suppliers to more than 70 countries. Svizera Labs Private Limited is approved by the World Health Organization (WHO) Geneva and holds a WHO-GMP and EU-GMP license (see link below).
Due to our joint venture with Svizera Labs Private Limited and through close cooperation with our partners, we are able to invest in the development of new products that contribute to the improvement of treatment of Tuberculosis worldwide.
Products which have been developed as a result of this unique cooperation are:
4-Fixed Dose Combination of anti-TB drugs as mentioned in the Essential Medicines List of the WHO.
Stop TB Patient Kits for the treatment of category I, II and III patients.